Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Lauren A. Baldwin, John T. Hoff, Jason Lefringhouse, Michael Zhang, Changhe Jia, Zeyi Liu, Sonia Erfani, Hongyan Jin, Mei Xu, Qing-Bai She, John R. van Nagell, Chi Wang, Li Chen, Rina Plattner, David M. Kaetzel, Jia Luo, Michael Lu, Dava West, Chunming Liu, Fred R. Ueland, Ronny Drapkin, Binhua P. Zhou, Xiuwei H. Yang
Published Oct 22, 2014 · Vol. 5, No. 23 · pp. 12203-12217
Alessandra Bisio, Judit Zámborszky, Sara Zaccara, Mattia Lion, Toma Tebaldi, Vasundhara Sharma, Ivan Raimondi, Federica Alessandrini, Yari Ciribilli, Alberto Inga
Published Oct 21, 2014 · Vol. 5, No. 23 · pp. 12111-12125
Keywords: p53, NFkB, chemotherapy, doxorubicin, TNFï¡ï€» EMT, synergy, breast cancer
Yi Lun Liu, Fritz Lai, James S. Wilmott, Xu Guang Yan, Xiao Ying Liu, Qi Luan, Su Tang Guo, Chen Chen Jiang, Hsin-Yi Tseng, Richard A. Scolyer, Lei Jin, Xu Dong Zhang
Published Oct 21, 2014 · Vol. 5, No. 22 · pp. 11237-11251
Jun-Bum Park, Sameer Agnihotri, Brian Golbourn, Kelsey C. Bertrand, Amanda Luck, Nesrin Sabha, Christian A. Smith, Sara Byron, Gelareh Zadeh, Sidney Croul, Michael Berens, James T. Rutka
Published Sep 5, 2014 · Vol. 5, No. 19 · pp. 9382-9395